
WEST PHARMACEUTICAL SERVICES
WSTNYSE๐ #437 by market capEarnings Oct 22US Equity
$351.37โผ $0.77 (โ0.22%)
Market closed ยท at close1hโ
24hโผ 0.2%
7dโฒ 0.1%
14dโฒ 4.1%
30dโผ 2.3%
1yโฒ 46.4%
๐ฆMarket Cap
$24.73B
Mid Cap
๐Revenue Growth (YoY)
+12.4%
Healthy
๐Gross Margin
36.8%
Healthy
๐ตFCF Margin
13.1%
Healthy
โ๏ธP/S Ratio
7.5x
Fair
Otter Score
44
Weak
๐
Analyst Ratings
Price
$351.37
Total
15
Raised
2
Lowered
1
Avg PT
$383.14
H / L
$447 / $315
| Institution | Action | Rating | Date |
|---|---|---|---|
Evercore ISI Group | Reiterated | Outperform | 2026-07-27 |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-09 |
Keybanc | Reiterated | Overweight | 2026-07-02 |
Barclays | Upgraded | Equal Weight โ Overweight | 2026-06-09 |
Stephens & Co. | Reiterated | Overweight | 2026-06-02 |
UBS | Reiterated | Buy | 2025-10-24 |
B of A Securities | Reiterated | Buy | 2024-12-13 |
Jefferies | Upgraded | Hold โ Buy | 2024-02-07 |
Deutsche Bank | Reiterated | Hold | 2022-12-14 |
KeyBanc | Reiterated | Overweight | 2020-11-10 |
Bank of America | Downgraded | Neutral โ Underperform | 2019-12-12 |
William Blair | Reiterated | Outperform | 2019-04-23 |
Goldman Sachs | Reiterated | Neutral | 2018-01-24 |
Wells Fargo | Reiterated | Outperform | 2017-10-27 |
Janney Capital | Reiterated | Buy | 2016-01-08 |
One row per institution, most recent rating